Medical Cyclotron Market Size, Share & Trends Report

Medical Cyclotron Market Size, Share & Trends Analysis Report by Product (10-12 MeV, 16-18 MeV, 19-24 MeV, 24 MeV & Above), By Region (North America, Europe, APAC, LATAM, MEA), and Segment Forecasts, 2018 - 2025

  • Published Date: Apr, 2018
  • Base Year for Estimate: 2016
  • Report ID: GVR-2-68038-159-7
  • Format: Electronic (PDF)
  • Historical Data: 2014 - 2016
  • Number of Pages: 99

Industry Insights

The global medical cyclotron market size was valued at USD 118.2 million in 2016. It is anticipated to expand at a CAGR of 10.9 % over the forecast period. Increasing prevalence of cancer, growing inclination towards nuclear scans for accurate diagnosis, cost advantage as compared to outsourced radioactive tracers, and availability of technologically advanced diagnostic devices are among key trends triggering market growth.

Radiotherapy is one of the technologically advanced methods used in diagnosis and treatment of cancerous cells. According to the World Nuclear Association, about 40 million procedures are carried out each year globally with nuclear medicines, with an annual growth of 5% per annum.

Japan medical cyclotron market

It is estimated that in developed economies, one in fifty patients use nuclear medicines for diagnosis each year and one-tenth of this population is treated with radioisotopes. Hence, the number of patients using nuclear diagnostics is expected to increase in the near future owing to their accuracy, which in turn will provide a significant push to the market.

Growing number of PET cyclotrons and closing of nuclear reactors such as Tomari nuclear plant in Japan is projected to augment the market. Introduction of upgraded devices with built-in shield and technological compatibility with PET & SPECT devices is responsible for increase in the acceptability of these devices. Rising acceptability of cyclotrons is poised to escalate the growth of the market.

Product Insights

On the basis of product, the market has been segmented into 10-12 MeV, 16-18 MeV, 19 -24 MeV, and 24 MeV and above. Cyclotrons in the range of 16 to 18 MeV dominated the market and accounted for more than 55.0% of the overall market revenue in 2016. The growth of the segment can be attributed to soaring demand for nuclear scans, increasing prevalence of cancer, and rising cancer awareness. Cyclotrons ranging from 10-12 MeV also command a substantial share in the market. Their prominence can be attributed to their use in hospitals and diagnostic centers for nuclear scans.

Cyclotrons in the range of 10 to 12 MeV are smaller in size as compared to other particle accelerators. They are available as shielded & unshielded, thus providing a wide range of options for healthcare professionals. These devices are equipped with dual-particle capability based on dual-target irradiations such as proton beam current of 60 μA to 130 μA and deuteron beam current of 60 μA. Asia Pacific has the highest number of cyclotrons in the range of 16-18 MeV, owing to its higher demand in hospitals and diagnostic centers for nuclear scans.

Cyclotrons ranging between 19 to 24 MeV are cost-effective solutions for the production of SPECT & PET radioisotopes used for medical purposes and in research institutions. These accelerators are medium-energy and high-current accelerators used to produce commercial quantities of SPECT isotopes, for instance, Ga-67, Ge-68, I-123, In-111, as well as other traditional PET isotopes. Cyclotrons in the range of 19-24MeV are best suitable for various research, diagnostic, and treatment needs of customers. The 19 to 24 MeV segment is likely to witness the highest CAGR in terms of revenue during 2017 to 2025.

Growing acceptance for PET-associated medical accelerators for the treatment and diagnosis of cancer is anticipated to promote the demand for medical cyclotrons. With an upswing in cancer awareness, the number of nuclear scans is also increasing. Increasing demand for nuclear scans and increase in cancer awareness is estimated to drive the global medical cyclotron market.

Regional Insights

Asia Pacific accounted for the highest share in the market in 2016. The region is expected to maintain its dominance throughout the forecast period, owing to spiraling demand for nuclear scans and widening base of cancer patients. Besides this, increasing investments in healthcare infrastructure, shutdown of nuclear reactors, and growing demand for cost-effective options are contributing to the growth of the regional market.

As of 2016, Japan was the at the forefront of the APAC market. The country will continue to the leading revenue contributor with a share of about 77.0% by 2025. Due to easy availability of radioactive tracers, the number of nuclear scans is projected to increase in this region during the forecast period.

In 2012, Japan closed its last nuclear reactor at Tomari nuclear plant. This nuclear plant was the source of radioactive isotopes used as radioactive tracers in medical diagnosis. Hence, Japan witnessed the installation of the highest number of new particle accelerators and is poised to install 49 new accelerators by 2025. With high demand for medical cyclotrons in Asia Pacific, the market is likely to witness a CAGR of 11.6% in terms of revenue over the forecast period.

Global medical cyclotron market

European market is anticipated to exhibit a CAGR of 11.1% over the forecast period. Europe is estimated to hold the second largest volume share throughout the forecast period. The region will remain a prominent destination for market players owing to high prevalence of cancer, increasing cancer diagnostic procedures, and rising awareness regarding nuclear scans.

The International Atomic Energy Agency (IAEA) is a regulatory body that authorizes the installation of particle accelerators. IAEA has stringent regulatory guidelines that must be considered while installing these devices in any European country. These well-defined regulatory guidelines help to maintain patient safety around these radioactive devices.

Medical Cyclotron Market Share Insights

The market is dominated by few key players, such as IBA; GE Healthcare; Siemens Medical Solutions USA, Inc.; Advanced Cyclotron Systems; Sumitomo Heavy Industries, Ltd.; and TeamBest (Best Medical International, Inc.).

The market is oligopolistic in nature, owing to which there is a fierce competition among existing players. Manufacturers face high market entry barriers and strict regulatory compliance along with higher setup cost for manufacturing of these devices. As a result, there are only a few players who account for a larger market share. However, some companies such as TeamBest is developing an innovative product with the capacity of 400 MeV for particle therapy with heavy ions, which are expected to provide more accurate diagnosis and treatment of cancer.

Report Scope

Attribute

Details

Base year for estimation

2016

Actual estimates/Historical data

2014 - 2016

Forecast period

2017 - 2025

Market representation                         

Revenue in USD Million, Volume in Units, and CAGR from 2017 to 2025

Regional scope

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Country scope

U.S., Canada, U.K., Germany, Japan, Australia, Brazil, Mexico, South Africa

Report coverage  

Revenue forecast, company share, competitive landscape, growth factors, and trends

15% free customization scope (equivalent to 5 analyst working days)

If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization


Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the global medical cyclotron market report on the basis of product type and region:

  • Product Type Outlook (Revenue, USD Million, Volume Units, 2014 - 2025)

    • Cyclotron 10-12 MeV

    • Cyclotron 16-18 MeV

    • Cyclotron 19-24 MeV

    • Cyclotron 24 MeV & above

  • Regional Outlook (Revenue, USD Million, Volume Units, 2014 - 2025)

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • U.K.

    • Asia Pacific

      • Japan

      • Australia

    • Latin America

      • Brazil

      • Mexico

    • Middle East & Africa

      • South Africa

Key questions answered by the report
Request for Customization

Choose License Type

Single User - $4,950
Multi User (2-5) - $5,950
Enterprise Access - $7,950

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert.

  • Custom research service

    Custom research service

    Design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • grand view research PCI DSS complaint grand view research paypal verified